From: Pharmacological significance of heterocyclic 1H-benzimidazole scaffolds: a review
Comp. | (Mean ± SEM) tail withdrawing time in second | ||||
---|---|---|---|---|---|
0Â h | 1Â h | 2Â h | 3Â h | 4Â h | |
Control (0.5% CMC) | 1.56 ± 0.16 | 2.16 ± 0.16 | 2.33 ± 0.21 | 2.66 ± 0.21 | 2.82 ± 0.72 |
Pentazocine | 2.16 ± 0.16 | 8.5 ± 0.34 | 11.33 ± 0.21 | 10.16 ± 0.30 | 10.83 ± 0.30 |
21a | 2.0 ± 0.25 | 3.0 ± 0.25 | 4.16 ± 0.33 | 10.5 ± 0.22 | 9.83 ± 0.33 |
21b | 2.0 ± 0.25 | 4.33 ± 0.21 | 3.73 ± 0.30 | 8.63 ± 0.21 | 10.03 ± 0.30 |
21c | 2.0 ± 0.25 | 6.51 ± 0.21 | 7.83 ± 0.30 | 9.73 ± 0.21 | 9.25 ± 0.30 |